Cumberland Pharmaceuticals Inc. (CPIX) Operating income 2016–2025
Cumberland Pharmaceuticals Inc. (CPIX) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2025 · since FY2016: -$1.4M → -$2.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | +56.6% |
| FY2024 | -$6.4M | +32.7% |
| FY2023 | -$9.6M | -67.5% |
| FY2022 | -$5.7M | +25.7% |
| FY2021 | -$7.7M | -20.3% |
| FY2020 | -$6.4M | +31.3% |
| FY2019 | -$9.3M | +16.9% |
| FY2018 | -$11.2M | -173.8% |
| FY2017 | -$4.1M | -184.8% |
| FY2016 | -$1.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CPIX financial trends
CPIX RevenueCPIX Net incomeCPIX Net marginCPIX Gross profitCPIX Gross marginCPIX Operating marginCPIX Operating cash flowCPIX Free cash flowCPIX Capital expendituresCPIX Return on equityCPIX Stock buybacksCPIX Dividends paidCPIX Total assetsCPIX Total liabilitiesCPIX Shareholders’ equityCPIX overview →